Next Day Disclosure Returns - [Others] Next Day Disclosure Returns
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2020
Announcements and Notices - [Inside Information / Other - Trading Update] CERTAIN UNAUDITED FINANCIAL INFORMATION FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2020
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2020
Announcements and Notices - [Other - Business Update] CHANGE IN USE OF NET PROCEEDS FROM THE GLOBAL OFFERING
Announcements and Notices - [Change in Chief Executive / Change in Directors or of Important Executive Functions or Responsibilities] APPOINTMENT OF VICE CHAIRMAN OF THE BOARD AND CHIEF EXECUTIVE OFFICER AND CHANGE OF AUTHORISED REPRESENTATIVE
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2020
Financial Statements/ESG Information - [Interim/Half-Year Report] INTERIM REPORT 2020
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2020
Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW DRUG APPLICATION FOR BEVACIZUMAB INJECTION (TAB008, A BIOSIMILAR TO AVASTIN) BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
Announcements and Notices - [Results of EGM/SGM] POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 21 AUGUST 2020
Announcements and Notices - [Interim Results] INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2020
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2020
Announcements and Notices - [Date of Board Meeting] DATE OF BOARD MEETING
Announcements and Notices - [Notice of EGM/SGM] NOTICE OF EXTRAORDINARY GENERAL MEETING
Circulars - [Issue of Shares / Connected Transaction / Other] GRANT OF AWARD SHARES UNDER RESTRICTED SHARE AWARD SCHEME INVOLVING ISSUE OF NEW SHARES UNDER SPECIFIC MANDATE, CONNECTED TRANSACTION INVOLVING ISSUE OF NEW SHARES TO TRUSTEE HOLDING SHARES ON TRUST FOR CERTAIN DIRECTORS, AND NOTICE OF EXTRAORDINARY GENERAL MEETING
Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT - COMPLETION OF DOSING IN THE FIRST PATIENT FOR THE PHASE III CLINICAL TRIAL OF TAA013, AN ANTIBODY DRUG CONJUGATE
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2020
Financial Statements/ESG Information - [Environmental, Social and Governance Information/Report] 2019 ENVIRONMENTAL, SOCIAL AND GOVERNANCE (ESG) REPORT
Announcements and Notices - [Results of AGM] POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 24 JUNE 2020
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2020
Announcements and Notices - [Issue of Shares under a Specific Mandate / Connected Transaction / Other - Miscellaneous] (1) ADOPTION OF RESTRICTED SHARE AWARD SCHEME (2) GRANT OF AWARD SHARES UNDER THE SCHEME (3) CONNECTED TRANSACTION INVOLVING ISSUE OF NEW SHARES TO TRUSTEE HOLDING SHARES ON TRUST FOR CERTAIN DIRECTORS
Announcements and Notices - [Notice of AGM] NOTICE OF ANNUAL GENERAL MEETING
Circulars - [General Mandate / Explanatory Statement for Repurchase of Shares / Re-election or Appointment of Director subject to Shareholders' Approval] PROPOSALS FOR GENERAL MANDATES TO ISSUE AND BUY BACK SHARES, RE-ELECTION OF RETIRING DIRECTORS, AND NOTICE OF ANNUAL GENERAL MEETING
Announcements and Notices - [Inside Information / Other - Trading Update] CERTAIN UNAUDITED FINANCIAL INFORMATION FOR THE THREE MONTHS ENDED 31 MARCH 2020
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2020
Financial Statements/ESG Information - [Annual Report] ANNUAL REPORT 2019
Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities] APPOINTMENT OF CHIEF OPERATING OFFICER
Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT - MEETING OF PRIMARY ENDPOINT IN PHASE III CLINICAL TRIAL OF TAB008
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2020
Announcements and Notices - [Final Results] ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2019
Announcements and Notices - [Date of Board Meeting] DATE OF BOARD MEETING
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2020
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2020
Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2019
Announcements and Notices - [Other - Business Update] VOLUNTARY ANNOUNCEMENT - LISTING OF CLINICAL RESEARCH AND COMMERCIALIZATION PROJECT IN RELATION TO TAB014 AS A SPECIAL MAJOR PROJECT FOR TECHNOLOGIES OF INNOVATIVE MANUFACTURING OF MAJOR NEW DRUGS IN CHINA